Louis J Fabri

Author PubWeight™ 11.07^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	SOCS2 negatively regulates growth hormone action in vitro and in vivo.	J Clin Invest	2005	1.66
2	Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor α1.	Biochem J	2013	1.45
3	SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities.	Biochemistry	2002	1.27
4	Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling.	J Biol Chem	2002	1.26
5	Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides.	J Med Chem	2008	1.17
6	Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain.	FEBS J	2005	1.14
7	Endogenous IL-11 signaling is essential in Th2- and IL-13-induced inflammation and mucus production.	Am J Respir Cell Mol Biol	2008	0.91
8	One-step zero-background IgG reformatting of phage-displayed antibody fragments enabling rapid and high-throughput lead identification.	Nucleic Acids Res	2013	0.80
9	EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE).	PLoS One	2013	0.79
10	Crystal structure of vascular endothelial growth factor-B in complex with a neutralising antibody Fab fragment.	J Mol Biol	2008	0.78